Hypoxic augmentation of Ca2+channel currents requires a functional electron transport chain

被引:15
作者
Brown, ST
Scragg, JL
Boyle, JP
Hudasek, K
Peers, C
Fearon, IM
机构
[1] Univ Manchester, Fac Life Sci, Manchester M13 9PT, Lancs, England
[2] Univ Leeds, Sch Med, Leeds LS2 9JT, W Yorkshire, England
[3] McMaster Univ, Dept Biol, Hamilton, ON L8S 4K1, Canada
关键词
D O I
10.1074/jbc.M503144200
中图分类号
Q5 [生物化学]; Q7 [分子生物学];
学科分类号
071010 ; 081704 ;
摘要
The incidence of Alzheimer disease is increased following ischemic episodes, and we previously demonstrated that following chronic hypoxia (CH), amyloid b (Ab) peptide-mediated increases in voltage-gated L-type Ca-2(2+ channel activity contribute to the Ca2+ dyshomeostasis seen in Alzheimer disease. Because in certain cell types mitochondria are responsible for detecting altered O) (levels we examined the role of mitochondrial oxidant production in the regulation of recombinant Ca2+ channel a)(1C) (subunits during CH and exposure to Ab-(1-40). In wild-type (r+) HEK 293 cells expressing recombinant L-type a)(1C) (subunits, Ca2+ currents were enhanced by prolonged (24 h) exposure to either CH (6% O)() or Ab-(1-40) (50 nM). By contrast the response to CH was absent in r0 cells in which the mitochondrial electron transport chain (ETC) was depleted following long term treatment with ethidium bromide or in r+ cells cultured in the presence of 1 mM rotenone. CH was mimicked in r0 cells by the exogenous production of O)(2)(2). by xanthine/xanthine oxidase. Furthermore Ab-(1-40) enhanced currents in r0 cells to a degree similar to that seen in cells with an intact ETC. The antioxidants ascorbate (200 mM) and Trolox (500 mM) ablated the effect of CH in r+ cells but were without effect on Ab-(1-40)-mediated augmentation of Ca2+ current in r0 cells. Thus oxidant production in the mitochondrial ETC is a critical factor, acting upstream of amyloid b peptide production in the up-regulation of Ca2+ channels in response to CH.
引用
收藏
页码:21706 / 21712
页数:7
相关论文
共 35 条
[1]   β-amyloid peptides induce mitochondrial dysfunction and oxidative stress in astrocytes and death of neurons through activation of NADPH oxidase [J].
Abramov, AY ;
Canevari, L ;
Duchen, MR .
JOURNAL OF NEUROSCIENCE, 2004, 24 (02) :565-575
[2]   Hypoxia inhibits the recombinant alpha(1C) subunit of the human cardiac L-type Ca2+ channel [J].
Fearon, IM ;
Palmer, ACV ;
Balmforth, AJ ;
Ball, SG ;
Mikala, G ;
Schwartz, A ;
Peers, C .
JOURNAL OF PHYSIOLOGY-LONDON, 1997, 500 (03) :551-556
[3]   Divergent pathways account for two distinct effects of amyloid β peptides on exocytosis and Ca2+ currents:: involvement of ROS and NF-κB [J].
Green, KN ;
Peers, C .
JOURNAL OF NEUROCHEMISTRY, 2002, 81 (05) :1043-1051
[4]   Hypoxia potentiates exocytosis and Ca2+ channels in PC12 cells via increased amyloid β peptide formation and reactive oxygen species generation [J].
Green, KN ;
Boyle, JP ;
Peers, C .
JOURNAL OF PHYSIOLOGY-LONDON, 2002, 541 (03) :1013-1023
[5]   Amyloid β peptides mediate hypoxic augmentation of Ca2+ channels [J].
Green, KN ;
Peers, C .
JOURNAL OF NEUROCHEMISTRY, 2001, 77 (03) :953-956
[6]   IMPROVED PATCH-CLAMP TECHNIQUES FOR HIGH-RESOLUTION CURRENT RECORDING FROM CELLS AND CELL-FREE MEMBRANE PATCHES [J].
HAMILL, OP ;
MARTY, A ;
NEHER, E ;
SAKMANN, B ;
SIGWORTH, FJ .
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY, 1981, 391 (02) :85-100
[7]   Post-transcriptional control of human maxiK potassium channel activity and acute oxygen sensitivity by chronic hypoxia [J].
Hartness, ME ;
Brazier, SP ;
Peers, C ;
Bateson, AN ;
Ashford, MLJ ;
Kemp, PJ .
JOURNAL OF BIOLOGICAL CHEMISTRY, 2003, 278 (51) :51422-51432
[8]   A MODEL FOR BETA-AMYLOID AGGREGATION AND NEUROTOXICITY BASED ON FREE-RADICAL GENERATION BY THE PEPTIDE - RELEVANCE TO ALZHEIMER-DISEASE [J].
HENSLEY, K ;
CARNEY, JM ;
MATTSON, MP ;
AKSENOVA, M ;
HARRIS, M ;
WU, JF ;
FLOYD, RA ;
BUTTERFIELD, DA .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1994, 91 (08) :3270-3274
[9]   Amyloid precursor protein processing and A beta(42) deposition in a transgenic mouse model of Alzheimer disease [J].
JohnsonWood, K ;
Lee, M ;
Motter, R ;
Hu, K ;
Gordon, G ;
Barbour, R ;
Khan, K ;
Gordon, M ;
Tan, H ;
Games, D ;
Lieberburg, I ;
Schenk, D ;
Seubert, P ;
McConlogue, L .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 1997, 94 (04) :1550-1555
[10]   The reduction of NADH Ubiquinone oxidoreductase 24-and 75-kDa subunits in brains of patients with Down syndrome and Alzheimer's disease [J].
Kim, SH ;
Vlkolinsky, R ;
Cairns, N ;
Fountoulakis, M ;
Lubec, G .
LIFE SCIENCES, 2001, 68 (24) :2741-2750